Spry's compounded GLP-1 medications are designed to help you lose weight, reduce food cravings, and give you more energy.
Get rid of obsessive dieting or compulsive snacking. Semaglutide quiets your appetite so you can focus on living instead of eating or not eating.
Patients lose an average of 10–15% of their body weight, and they keep it off with continued treatment.
Stable blood sugar means fewer crashes, less fatigue, and more energy all day.
Most patients notice an appetite decrease and energy increase within the first 2–4 weeks of treatment.
If you've set a significant weight loss goal, this clinically advanced option will help you reach it.
Research shows the weight loss, the appetite decrease, and the energy increase from Tirzepatide all last while your treatment continues.
Tell us about your health, your lifestyle, and your goals.
You receive a simple, handcrafted treatment plan.
We ship your treatment quickly so you can start achieving your health goals.
"I've tried every diet out there. Spry and Semaglutide finally gave me the tool I needed. I've lost 32 lbs in 4 months and I feel incredible."
"The whole process was so easy. I did everything from my phone, got my medication in days, and the support team has been amazing throughout."
"Tirzepatide through Spry changed my life. My doctor here is attentive and the price is way better than what my insurance quoted me."
"I was skeptical about online prescriptions, but the whole experience has been incredibly professional. Down 25 lbs and counting."
Clinical trials show patients lose an average of 15% body weight while taking semaglutide.
GLP-1 medications reduce cardiovascular risk in addition to promoting weight loss.
Over 85% of patients maintain weight loss results at the 1-year mark with consistent use.
GLP-1 medications quiet your food cravings and give you more energy by mimicking a natural hormone that regulates appetite and blood sugar.
Most patients feel a reduced appetite within 1-2 weeks and typically see visible weight loss within 4-8 weeks.
Yes. Our licensed medical professionals review your lifestyle and health profile, then prescribe you with the right dosage to meet your body's needs and your goals.
Tirzepatide is a more aggressive weight loss treatment because it targets two hormone receptors (GLP-1 and GIP) instead of one. The dual targeting may lead to enhanced weight loss and better metabolic outcomes for some patients.
Join thousands who've already transformed their health with Spry. Your personalized plan is just minutes away.
No commitment • Cancel anytime • HIPAA compliant
The information provided on this website is for informational purposes only and does not constitute medical advice. GLP-1 medications require a prescription and are only available after evaluation by a licensed healthcare provider. Individual results may vary. Spry does not guarantee specific weight loss outcomes. Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are registered trademarks of their respective owners. Spry is not affiliated with or endorsed by these brands.